|
🐜
|
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.
35 auth.
Esra A. Akbay,
Esra A. Akbay,
S. Koyama,
J. Carretero,
Abigail Altabef,
Abigail Altabef,
J. Tchaicha,
J. Tchaicha,
Camilla L Christensen,
Camilla L Christensen,
Oliver Mikse,
Oliver Mikse,
A. Cherniack,
Ellen M. Beauchamp,
Trevor J. Pugh,
...
M. Wilkerson,
P. Fecci,
M. Butaney,
J. Reibel,
J. Reibel,
Margaret Soucheray,
Travis J. Cohoon,
Travis J. Cohoon,
P. Jänne,
M. Meyerson,
M. Meyerson,
D. N. Hayes,
Geoffrey I. Shapiro,
T. Shimamura,
L. Sholl,
S. Rodig,
G. Freeman,
P. Hammerman,
G. Dranoff,
Kwok-kin Wong
|
10 |
2013 |
10
🐜
|
|
🐜
|
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
69 auth.
F. Skoulidis,
M. Goldberg,
D. Greenawalt,
M. Hellmann,
M. Awad,
J. Gainor,
A. Schrock,
R. Hartmaier,
S. Trabucco,
L. Gay,
Siraj M. Ali,
J. Elvin,
G. Singal,
J. Ross,
D. Fabrizio,
...
P. Szabo,
Han Chang,
A. Sasson,
S. Srinivasan,
S. Kirov,
J. Szustakowski,
P. Vitazka,
R. Edwards,
J. Bufill,
N. Sharma,
S. Ou,
N. Peled,
D. Spigel,
H. Rizvi,
E. J. Aguilar,
B. Carter,
J. Erasmus,
D. Halpenny,
A. Plodkowski,
N. Long,
M. Nishino,
W. Denning,
Ana Galán‐Cobo,
Haifa Hamdi,
Taghreed Hirz,
P. Tong,
Jing Wang,
J. Rodriguez-Canales,
P. Villalobos,
E. Parra,
N. Kalhor,
L. Sholl,
J. Sauter,
A. Jungbluth,
M. Mino‐Kenudson,
Roxana Azimi,
Y. Elamin,
Jianjun Zhang,
G. Leonardi,
F. Jiang,
Kwok-kin Wong,
J. Lee,
V. Papadimitrakopoulou,
I. Wistuba,
V. Miller,
G. Frampton,
J. Wolchok,
A. Shaw,
P. Jänne,
P. Stephens,
C. Rudin,
W. Geese,
L. Albacker,
J. Heymach
|
10 |
2018 |
10
🐜
|
|
🐜
|
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
10 auth.
D. Doroshow,
S. Bhalla,
M. Beasley,
L. Sholl,
K. Kerr,
S. Gnjatic,
...
I. Wistuba,
D. Rimm,
M. Tsao,
F. Hirsch
|
9 |
2021 |
9
🐜
|
|
🐜
|
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
22 auth.
N. Lindeman,
P. Cagle,
D. Aisner,
M. Arcila,
M. Beasley,
E. Bernicker,
Carol Colasacco,
S. Dacic,
F. Hirsch,
K. Kerr,
...
D. Kwiatkowski,
M. Ladanyi,
J. Nowak,
L. Sholl,
Robyn L. Temple-Smolkin,
B. Solomon,
L. Souter,
E. Thunnissen,
M. Tsao,
Christina B. Ventura,
M. Wynes,
Y. Yatabe
|
9 |
2018 |
9
🐜
|
|
🐜
|
The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.
19 auth.
A. Nicholson,
M. Tsao,
M. Beasley,
A. Borczuk,
E. Brambilla,
W. Cooper,
S. Dacic,
D. Jain,
K. Kerr,
S. Lantuejoul,
...
M. Noguchi,
M. Papotti,
N. Rekhtman,
G. Scagliotti,
P. V. Van Schil,
L. Sholl,
Y. Yatabe,
A. Yoshida,
W. Travis
|
9 |
2021 |
9
🐜
|
|
🐢
|
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.
13 auth.
M. Awad,
G. Oxnard,
D. Jackman,
Daniel O Savukoski,
Dimity L Hall,
Priyanka Shivdasani,
J. Heng,
S. Dahlberg,
P. Jänne,
Suman Verma,
...
J. Christensen,
P. Hammerman,
L. Sholl
|
9 |
2016 |
9
🐢
|
|
🐜
|
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.
12 auth.
B. Howitt,
S. Shukla,
L. Sholl,
Lauren L. Ritterhouse,
J. Watkins,
S. Rodig,
...
E. Stover,
K. Strickland,
A. D’Andrea,
Catherine J. Wu,
U. Matulonis,
P. Konstantinopoulos
|
9 |
2015 |
9
🐜
|
|
🐜
|
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
15 auth.
G. Oxnard,
Yuebi Hu,
K. Mileham,
H. Husain,
D. Costa,
P. Tracy,
N. Feeney,
L. Sholl,
S. Dahlberg,
A. Redig,
...
D. Kwiatkowski,
M. Rabin,
C. Paweletz,
K. Thress,
P. Jänne
|
9 |
2018 |
9
🐜
|
|
🐜
|
Liquid Biopsy for Advanced Non‐Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
23 auth.
C. Rolfo,
P. Mack,
G. Scagliotti,
P. Baas,
F. Barlesi,
T. Bivona,
R. Herbst,
T. Mok,
N. Peled,
R. Pirker,
...
L. Raez,
M. Reck,
J. Riess,
L. Sequist,
F. Shepherd,
L. Sholl,
D. Tan,
H. Wakelee,
I. Wistuba,
M. Wynes,
D. Carbone,
F. Hirsch,
D. Gandara
|
9 |
2018 |
9
🐜
|
|
🐜
|
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
44 auth.
Diana Miao,
Diana Miao,
Claire A. Margolis,
Claire A. Margolis,
N. Vokes,
N. Vokes,
David R. Liu,
David Liu,
A. Taylor-Weiner,
A. Taylor-Weiner,
Stephanie A. M. Wankowicz,
Stephanie A. M. Wankowicz,
D. Adeegbe,
Daniel Keliher,
Daniel Keliher,
...
B. Schilling,
A. Tracy,
M. Manos,
N. Chau,
G. Hanna,
P. Polak,
S. Rodig,
S. Rodig,
S. Signoretti,
S. Signoretti,
L. Sholl,
L. Sholl,
J. Engelman,
G. Getz,
P. Jänne,
R. Haddad,
T. Choueiri,
D. Barbie,
Rizwan Haq,
Rizwan Haq,
M. Awad,
D. Schadendorf,
F. Hodi,
J. Bellmunt,
Kwok-kin Wong,
Kwok-kin Wong,
P. Hammerman,
E. V. Allen,
E. Allen
|
8 |
2018 |
8
🐜
|
|
🐜
|
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
44 auth.
Diana Miao,
Diana Miao,
Claire A. Margolis,
Claire A. Margolis,
N. Vokes,
N. Vokes,
David R. Liu,
David Liu,
A. Taylor-Weiner,
A. Taylor-Weiner,
Stephanie A. M. Wankowicz,
Stephanie A. M. Wankowicz,
D. Adeegbe,
Daniel Keliher,
Daniel Keliher,
...
B. Schilling,
A. Tracy,
M. Manos,
N. Chau,
G. Hanna,
P. Polak,
S. Rodig,
S. Rodig,
S. Signoretti,
S. Signoretti,
L. Sholl,
L. Sholl,
J. Engelman,
G. Getz,
P. Jänne,
R. Haddad,
T. Choueiri,
D. Barbie,
Rizwan Haq,
Rizwan Haq,
M. Awad,
D. Schadendorf,
F. Hodi,
J. Bellmunt,
Kwok-kin Wong,
Kwok-kin Wong,
P. Hammerman,
E. V. Allen,
E. Allen
|
8 |
2018 |
8
🐜
|
|
🐜
|
PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course
10 auth.
M. Nishino,
N. Ramaiya,
M. Awad,
L. Sholl,
Jennifer A Maattala,
Myriam Taibi,
...
H. Hatabu,
P. Ott,
Philippe Armand,
Stephen F. Hodi
|
8 |
2016 |
8
🐜
|
|
🐜
|
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.
22 auth.
N. Lindeman,
P. Cagle,
D. Aisner,
M. Arcila,
M. Beasley,
E. Bernicker,
Carol Colasacco,
S. Dacic,
F. Hirsch,
K. Kerr,
...
D. Kwiatkowski,
M. Ladanyi,
J. Nowak,
L. Sholl,
Robyn L. Temple-Smolkin,
B. Solomon,
L. Souter,
E. Thunnissen,
M. Tsao,
Christina B. Ventura,
M. Wynes,
Y. Yatabe
|
8 |
2018 |
8
🐜
|
